胃腸道出血治療市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、胃腸道部位、最終用戶、地區和競爭格局分類，2020-2030年預測

2024年全球胃腸道出血治療市場規模為5.6244億美元，預計2030年將以5.88%的複合年成長率成長至7.9234億美元。全球胃腸道出血治療市場專注於旨在止血或控制胃腸道（包括食道、胃、小腸、大腸和直腸）出血的醫療干預措施，同時解決潛在病因並預防併發症。

主要市場促進因素

胃腸道疾病的日益普遍顯著地推動了全球胃腸道出血治療市場的發展。諸如消化性潰瘍、胃炎和大腸癌等疾病本身就存在出血風險，需要醫療介入。

主要市場挑戰

先進的診斷和治療設備及手術的高昂成本是全球胃腸道出血治療市場的重大挑戰。這種經濟障礙直接限制了市場擴張，限制了創新高效能干預措施的可近性和廣泛應用，特別是在醫療預算有限的醫療系統和發展中國家。

主要市場趨勢

遠距醫療和遠距監測在胃腸道出血管理的應用日益廣泛，標誌著醫療服務模式的重大變革。這一趨勢超越了傳統的面對面就診模式，旨在提供持續的患者追蹤和更完善的出院後護理。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球胃腸道出血治療市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依產品分類（閉合裝置、內視鏡止血裝置、其他）
  • 依消化道部位分類（上消化道、下消化道）
  • 依最終使用者（醫院/診所、門診手術中心、其他）分類
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美胃腸道出血治療市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲胃腸道出血治療市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區胃腸道出血治療市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲胃腸道出血治療市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲胃腸道出血治療市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章：全球胃腸道出血治療市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Boston Scientific Corporation
• Olympus Corporation
• CONMED Corporation
• Ovesco Endoscopy AG
• Erbe Elektromedizin GmbH
• Steris Plc
• US Medical Innovations, LLC
• Pfizer Inc.

第16章：策略建議

第17章調查會社について,免責事項

The Global Gastrointestinal Bleeding Treatment Market, valued at USD 562.44 Million in 2024, is projected to experience a CAGR of 5.88% to reach USD 792.34 Million by 2030. The Global Gastrointestinal Bleeding Treatment Market focuses on medical interventions designed to halt or manage blood loss originating within the gastrointestinal tract, encompassing the esophagus, stomach, small intestine, large intestine, and rectum, alongside addressing underlying causes and preventing complications.

Key Market Drivers

The increasing prevalence of gastrointestinal disorders significantly drives the Global Gastrointestinal Bleeding Treatment Market. Conditions such as peptic ulcers, gastritis, and colorectal cancer inherently carry a risk of bleeding, necessitating medical intervention. As the global burden of these diseases grows, the demand for effective diagnostic and therapeutic solutions for gastrointestinal bleeding escalates.

Key Market Challenges

The substantial cost associated with advanced diagnostic and therapeutic devices and procedures presents a significant challenging factor within the Global Gastrointestinal Bleeding Treatment Market. This financial impediment directly restrains market expansion by limiting the accessibility and widespread adoption of innovative, highly effective interventions, particularly in healthcare systems with constrained budgets and in developing nations. The high initial capital expenditure required for sophisticated endoscopes, specialized hemostatic instruments, and associated processing units often exceeds the financial capacity of numerous healthcare providers, hindering their ability to invest in these critical technologies.

Key Market Trends

The expansion of telehealth and remote monitoring in gastrointestinal bleeding management represents a significant evolution in healthcare delivery. This trend moves beyond traditional in-person visits to offer continuous patient oversight and enhanced post-discharge care. Telehealth platforms facilitate virtual consultations and enable remote patient monitoring through digital health tools, which supports timely interventions and improves patient engagement by providing convenience and accessibility, especially for individuals in remote areas or those facing mobility challenges.

Key Market Players

• Boston Scientific Corporation
• Olympus Corporation
• CONMED Corporation
• Ovesco Endoscopy AG
• Erbe Elektromedizin GmbH
• Steris Plc
• US Medical Innovations, LLC
• Pfizer Inc.

Report Scope:

In this report, the Global Gastrointestinal Bleeding Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gastrointestinal Bleeding Treatment Market, By Product:

• Closure Devices
• Endoscopic Hemostatic Devices
• Others

Gastrointestinal Bleeding Treatment Market, By GI Tract Division:

• Upper GI Tract
• Lower GI Tract

Gastrointestinal Bleeding Treatment Market, By End Users:

• Hospital/Clinics
• Ambulatory Surgical Centres
• Others

Gastrointestinal Bleeding Treatment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Gastrointestinal Bleeding Treatment Market.

Available Customizations:

Global Gastrointestinal Bleeding Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gastrointestinal Bleeding Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Closure Devices, Endoscopic Hemostatic Devices, Others)
  • 5.2.2. By GI Tract Division (Upper GI Tract, Lower GI Tract)
  • 5.2.3. By End Users (Hospital/Clinics, Ambulatory Surgical Centres, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Gastrointestinal Bleeding Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By GI Tract Division
  • 6.2.3. By End Users
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Gastrointestinal Bleeding Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By GI Tract Division
      • 6.3.1.2.3. By End Users
  • 6.3.2. Canada Gastrointestinal Bleeding Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By GI Tract Division
      • 6.3.2.2.3. By End Users
  • 6.3.3. Mexico Gastrointestinal Bleeding Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By GI Tract Division
      • 6.3.3.2.3. By End Users

7. Europe Gastrointestinal Bleeding Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By GI Tract Division
  • 7.2.3. By End Users
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Gastrointestinal Bleeding Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By GI Tract Division
      • 7.3.1.2.3. By End Users
  • 7.3.2. France Gastrointestinal Bleeding Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By GI Tract Division
      • 7.3.2.2.3. By End Users
  • 7.3.3. United Kingdom Gastrointestinal Bleeding Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By GI Tract Division
      • 7.3.3.2.3. By End Users
  • 7.3.4. Italy Gastrointestinal Bleeding Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By GI Tract Division
      • 7.3.4.2.3. By End Users
  • 7.3.5. Spain Gastrointestinal Bleeding Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By GI Tract Division
      • 7.3.5.2.3. By End Users

8. Asia Pacific Gastrointestinal Bleeding Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By GI Tract Division
  • 8.2.3. By End Users
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Gastrointestinal Bleeding Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By GI Tract Division
      • 8.3.1.2.3. By End Users
  • 8.3.2. India Gastrointestinal Bleeding Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By GI Tract Division
      • 8.3.2.2.3. By End Users
  • 8.3.3. Japan Gastrointestinal Bleeding Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By GI Tract Division
      • 8.3.3.2.3. By End Users
  • 8.3.4. South Korea Gastrointestinal Bleeding Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By GI Tract Division
      • 8.3.4.2.3. By End Users
  • 8.3.5. Australia Gastrointestinal Bleeding Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By GI Tract Division
      • 8.3.5.2.3. By End Users

9. Middle East & Africa Gastrointestinal Bleeding Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By GI Tract Division
  • 9.2.3. By End Users
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Gastrointestinal Bleeding Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By GI Tract Division
      • 9.3.1.2.3. By End Users
  • 9.3.2. UAE Gastrointestinal Bleeding Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By GI Tract Division
      • 9.3.2.2.3. By End Users
  • 9.3.3. South Africa Gastrointestinal Bleeding Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By GI Tract Division
      • 9.3.3.2.3. By End Users

10. South America Gastrointestinal Bleeding Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By GI Tract Division
  • 10.2.3. By End Users
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Gastrointestinal Bleeding Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By GI Tract Division
      • 10.3.1.2.3. By End Users
  • 10.3.2. Colombia Gastrointestinal Bleeding Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By GI Tract Division
      • 10.3.2.2.3. By End Users
  • 10.3.3. Argentina Gastrointestinal Bleeding Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By GI Tract Division
      • 10.3.3.2.3. By End Users

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Gastrointestinal Bleeding Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boston Scientific Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Olympus Corporation
• 15.3. CONMED Corporation
• 15.4. Ovesco Endoscopy AG
• 15.5. Erbe Elektromedizin GmbH
• 15.6. Steris Plc
• 15.7. US Medical Innovations, LLC
• 15.8. Pfizer Inc.

16. Strategic Recommendations

17. About Us & Disclaimer